+8613915297818
Home > Article > Fierce M & A in medical equipment industry

Fierce M & A in medical equipment industry

2016-09-06 09:27:33
     On June 18, at the China Health Industry Summit Forum of China Europe Business School, Guoxiang, deputy director of the consumer goods industry department of the Ministry of industry and information technology, mentioned that the national goal during the "13th five year plan" period is to achieve the advancement of the pharmaceutical industry to the medium and high end, and the guiding principles are innovation driven, quality first, guaranteed supply, intensive and open cooperation.

     Therefore, in the field of pharmaceutical industry, we should focus on doing some things. For those involving medical devices, we have noticed these: cooperation and innovation between industry, University and research, and strengthening the development and application of key components of core technologies of medical devices; Implement the national standard action plan for medical devices; Strengthen brand building, inherit the independent brand of medical devices, and the Ministry of industry and information technology, together with relevant departments, will come up with some specific tests; Develop household medical devices and improve their design and functions; Consolidate international positioning and expand the export scale of medical equipment.

     Guoxiang also specifically mentioned that the Ministry of industry and information technology is working out a merger and reorganization plan for the pharmaceutical industry, has set a goal for 10 years, and is seeking the opinions of experts, scientific research institutes, enterprises, etc. The State encourages industrial restructuring and optimization of industrial organization structure, especially supports the combination of strong enterprises, supports large enterprises to integrate small enterprises, and supports small enterprises to establish industrial alliances.

     Not surprisingly, the so-called document to be issued by the Ministry of industry and information technology should be the "13th five year plan" for the development of the pharmaceutical industry, which is directly connected with the "made in China 2025", and the industry has been looking forward to it for a long time.